- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/40 - CyclodextrinsDerivatives thereof
Patent holdings for IPC class A61K 47/40
Total number of patents in this class: 2017
10-year publication summary
|
77
|
127
|
147
|
188
|
196
|
212
|
167
|
167
|
170
|
133
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 282 |
98 |
| CyDex Pharmaceuticals, Inc. | 106 |
48 |
| Oculis Operations Sàrl | 36 |
19 |
| The Regents of the University of California | 20303 |
17 |
| Pfizer Inc. | 3401 |
17 |
| Aldeyra Therapeutics, Inc. | 106 |
17 |
| Novartis AG | 10612 |
15 |
| Massachusetts Institute of Technology | 10150 |
15 |
| The Brigham and Women's Hospital, Inc. | 2227 |
14 |
| Yale University | 2446 |
12 |
| Cardioxyl Pharmaceuticals, Inc. | 47 |
11 |
| Roquette Freres | 1027 |
11 |
| Boehringer Ingelheim Vetmedica GmbH | 1274 |
10 |
| Allergan, Inc. | 2313 |
10 |
| Sapiotec GmbH | 20 |
10 |
| Hikma Pharmaceuticals USA Inc. | 153 |
10 |
| Faes Farma, S.A. | 100 |
9 |
| Aardvark Therapeutics Inc. | 51 |
9 |
| Oncopeptides Innovation AB | 28 |
9 |
| Altergon S.A. | 91 |
8 |
| Other owners | 1648 |